Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
A Phase II Study of TLN-4601 in Patients With Glioblastoma Multiforme
Status: Enrolling
Updated:  12/29/2009
Duke University
2203
mi
from 91732
Durham, NC
Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
A Phase II Study of TLN-4601 in Patients With Glioblastoma Multiforme
Status: Enrolling
Updated: 12/29/2009
Duke University
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
A Phase II Study of TLN-4601 in Patients With Glioblastoma Multiforme
Status: Enrolling
Updated:  12/29/2009
Ottawa Health Research Institute
2348
mi
from 91732
Ottawa,
Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
A Phase II Study of TLN-4601 in Patients With Glioblastoma Multiforme
Status: Enrolling
Updated: 12/29/2009
Ottawa Health Research Institute
2348
mi
from 91732
Ottawa,
Click here to add this to my saved trials
Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
Pilot Study Evaluating the Feasibility of Real-Time, Magnetic Resonance Thermal Imaging and Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
Status: Enrolling
Updated:  12/30/2009
North Shore University Hospital
2448
mi
from 91732
Manhasset, NY
Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
Pilot Study Evaluating the Feasibility of Real-Time, Magnetic Resonance Thermal Imaging and Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
Status: Enrolling
Updated: 12/30/2009
North Shore University Hospital
2448
mi
from 91732
Manhasset, NY
Click here to add this to my saved trials
A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma
A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma
Status: Enrolling
Updated:  1/18/2010
Kentuckiana Cancer Institute, PLLC
1813
mi
from 91732
Louisville, KY
A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma
A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma
Status: Enrolling
Updated: 1/18/2010
Kentuckiana Cancer Institute, PLLC
1813
mi
from 91732
Louisville, KY
Click here to add this to my saved trials
A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
A Phase 2, Open-label, Proof-of-concept Study to Assess the Ability to Detect Tumours and Angiogenesis Via the Expression of ανβ3/5 Integrin Receptors by [18F]AH-111585 PET Imaging
Status: Enrolling
Updated:  3/25/2010
GE Healthcare Office
2400
mi
from 91732
Princeton, NJ
A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
A Phase 2, Open-label, Proof-of-concept Study to Assess the Ability to Detect Tumours and Angiogenesis Via the Expression of ανβ3/5 Integrin Receptors by [18F]AH-111585 PET Imaging
Status: Enrolling
Updated: 3/25/2010
GE Healthcare Office
2400
mi
from 91732
Princeton, NJ
Click here to add this to my saved trials
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
A Phase I Study of Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
Status: Enrolling
Updated:  5/3/2010
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
A Phase I Study of Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
Status: Enrolling
Updated: 5/3/2010
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
A Phase I Study of Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
Status: Enrolling
Updated:  5/3/2010
Dana-Farber Cancer Institute
2578
mi
from 91732
Boston, MA
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
A Phase I Study of Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
Status: Enrolling
Updated: 5/3/2010
Dana-Farber Cancer Institute
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated:  5/11/2010
Beth Israel Deaconess Medical Center
2578
mi
from 91732
Boston, MA
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated: 5/11/2010
Beth Israel Deaconess Medical Center
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated:  5/11/2010
Dana-Farber Cancer Institute
2578
mi
from 91732
Boston, MA
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated: 5/11/2010
Dana-Farber Cancer Institute
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated:  5/11/2010
Department of Radiation oncology, Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York city, NY
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated: 5/11/2010
Department of Radiation oncology, Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York city, NY
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated:  5/11/2010
UPMC Shadyside Radiation Oncology
2122
mi
from 91732
Pittsburgh, PA
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy
Status: Enrolling
Updated: 5/11/2010
UPMC Shadyside Radiation Oncology
2122
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated:  5/13/2010
Northwestern University - Robert H Lurie Comprehensive Cancer Center
1730
mi
from 91732
Chicago, IL
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated: 5/13/2010
Northwestern University - Robert H Lurie Comprehensive Cancer Center
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated:  5/13/2010
University of Kentucky, Markey Cancer Center
1881
mi
from 91732
Lexington, KY
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated: 5/13/2010
University of Kentucky, Markey Cancer Center
1881
mi
from 91732
Lexington, KY
Click here to add this to my saved trials
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated:  5/13/2010
North Shore - Long Island Jewish Hospital/Monter Cancer Center
2448
mi
from 91732
Lake Success, NY
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated: 5/13/2010
North Shore - Long Island Jewish Hospital/Monter Cancer Center
2448
mi
from 91732
Lake Success, NY
Click here to add this to my saved trials
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated:  5/13/2010
Duke University Medical Center, Preston Robert Tisch Brain Tumor Center
2203
mi
from 91732
Durham, NC
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated: 5/13/2010
Duke University Medical Center, Preston Robert Tisch Brain Tumor Center
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated:  5/13/2010
Derrick L Davis Forsyth Regional Cancer Center
2123
mi
from 91732
Winston-Salem, NC
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated: 5/13/2010
Derrick L Davis Forsyth Regional Cancer Center
2123
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated:  5/13/2010
The Ohio State University - James Comprehensive Cancer Center
1959
mi
from 91732
Columbus, OH
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated: 5/13/2010
The Ohio State University - James Comprehensive Cancer Center
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated:  5/13/2010
University of Utah - Huntsman Cancer Center
573
mi
from 91732
Salt Lake City, UT
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
A Phase 2 Study of AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin) in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Status: Enrolling
Updated: 5/13/2010
University of Utah - Huntsman Cancer Center
573
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Status: Enrolling
Updated:  6/1/2010
Rady Children's Hospital - San Diego
101
mi
from 91732
San Diego, CA
Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Status: Enrolling
Updated: 6/1/2010
Rady Children's Hospital - San Diego
101
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Status: Enrolling
Updated:  6/1/2010
SSM Cardinal Glennon Children's Medical Center
1572
mi
from 91732
St. Louis, MO
Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Status: Enrolling
Updated: 6/1/2010
SSM Cardinal Glennon Children's Medical Center
1572
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Status: Enrolling
Updated:  6/1/2010
Fletcher Allen Health Care
2467
mi
from 91732
Burlington, VT
Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
A Phase I Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including CNS Tumors
Status: Enrolling
Updated: 6/1/2010
Fletcher Allen Health Care
2467
mi
from 91732
Burlington, VT
Click here to add this to my saved trials
Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
Phase II Pilot Trial of Hyperbaric Hyperoxygenation in Conjunction With Radiotherapy and Temozolomide In Adults With Newly Diagnosed Glioblastomas
Status: Enrolling
Updated:  7/15/2010
Long Island Brain Tumor Center at Neurological surgery P.C.
2470
mi
from 91732
Commack, NY
Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
Phase II Pilot Trial of Hyperbaric Hyperoxygenation in Conjunction With Radiotherapy and Temozolomide In Adults With Newly Diagnosed Glioblastomas
Status: Enrolling
Updated: 7/15/2010
Long Island Brain Tumor Center at Neurological surgery P.C.
2470
mi
from 91732
Commack, NY
Click here to add this to my saved trials
Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
Phase II Pilot Trial of Hyperbaric Hyperoxygenation in Conjunction With Radiotherapy and Temozolomide In Adults With Newly Diagnosed Glioblastomas
Status: Enrolling
Updated:  7/15/2010
The Long Island Brain Tumor Center at Neurological Surgery, PC
2446
mi
from 91732
Great Neck, NY
Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
Phase II Pilot Trial of Hyperbaric Hyperoxygenation in Conjunction With Radiotherapy and Temozolomide In Adults With Newly Diagnosed Glioblastomas
Status: Enrolling
Updated: 7/15/2010
The Long Island Brain Tumor Center at Neurological Surgery, PC
2446
mi
from 91732
Great Neck, NY
Click here to add this to my saved trials
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
High-Dose Chemotherapy With Tandem Peripheral Blood Stem Cell (PBSC) Rescue for the Treatment of High-Risk Pediatric Solid Tumors.
Status: Enrolling
Updated:  10/7/2010
Children's Memorial Hospital
1728
mi
from 91732
Chicago, IL
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
High-Dose Chemotherapy With Tandem Peripheral Blood Stem Cell (PBSC) Rescue for the Treatment of High-Risk Pediatric Solid Tumors.
Status: Enrolling
Updated: 10/7/2010
Children's Memorial Hospital
1728
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma
A Pilot Study of Intravenous Topotecan and Vincristine in Combination With Subconjunctival Carboplatin for Patients With a History of Bilateral Retinoblastoma and Refractory/Recurrent Intraocular Disease (IND# 104,942)
Status: Enrolling
Updated:  12/10/2010
Cincinnati Children's Hospital Medical Center
1880
mi
from 91732
Cincinnati, OH
Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma
A Pilot Study of Intravenous Topotecan and Vincristine in Combination With Subconjunctival Carboplatin for Patients With a History of Bilateral Retinoblastoma and Refractory/Recurrent Intraocular Disease (IND# 104,942)
Status: Enrolling
Updated: 12/10/2010
Cincinnati Children's Hospital Medical Center
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
A Randomized Study of Antineoplaston Therapy vs. Temozolomide in Subjects With Recurrent and / or Progressive Optic Pathway Glioma
A Randomized Phase 3 Study of Combination Antineoplaston Therapy [Antineoplastons A10 (Atengenal) and AS2-1 (Astugenal)] vs. Temozolomide in Subjects With Recurrent and / or Progressive Optic Pathway Glioma After Carboplatin or Cisplatin Therapy
Status: Enrolling
Updated:  12/13/2010
Burzynski Research Institute, Inc
1349
mi
from 91732
Houston, TX
A Randomized Study of Antineoplaston Therapy vs. Temozolomide in Subjects With Recurrent and / or Progressive Optic Pathway Glioma
A Randomized Phase 3 Study of Combination Antineoplaston Therapy [Antineoplastons A10 (Atengenal) and AS2-1 (Astugenal)] vs. Temozolomide in Subjects With Recurrent and / or Progressive Optic Pathway Glioma After Carboplatin or Cisplatin Therapy
Status: Enrolling
Updated: 12/13/2010
Burzynski Research Institute, Inc
1349
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Randomized Study of Antineoplaston Therapy vs. Temozolomide in Subjects With Recurrent and / or Progressive Optic Pathway Glioma
A Randomized Phase 3 Study of Combination Antineoplaston Therapy [Antineoplastons A10 (Atengenal) and AS2-1 (Astugenal)] vs. Temozolomide in Subjects With Recurrent and / or Progressive Optic Pathway Glioma After Carboplatin or Cisplatin Therapy
Status: Enrolling
Updated:  12/13/2010
Burzynski Clinic
1348
mi
from 91732
Houston, TX
A Randomized Study of Antineoplaston Therapy vs. Temozolomide in Subjects With Recurrent and / or Progressive Optic Pathway Glioma
A Randomized Phase 3 Study of Combination Antineoplaston Therapy [Antineoplastons A10 (Atengenal) and AS2-1 (Astugenal)] vs. Temozolomide in Subjects With Recurrent and / or Progressive Optic Pathway Glioma After Carboplatin or Cisplatin Therapy
Status: Enrolling
Updated: 12/13/2010
Burzynski Clinic
1348
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
A Prospective Single Institution Study of Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Status: Enrolling
Updated:  4/21/2011
Allegheny General Neurology Department/Neuro-Oncology
2119
mi
from 91732
Pittsburgh, PA
Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
A Prospective Single Institution Study of Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Status: Enrolling
Updated: 4/21/2011
Allegheny General Neurology Department/Neuro-Oncology
2119
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Cell Culture of Glioma Specimens for in Vitro Preclinical Studies
Primary Cell Culture of Surgical Glioma Specimens for Invitro Preclinical Studies
Status: Enrolling
Updated:  6/24/2011
Albany Medical Center
2438
mi
from 91732
Albany, NY
Cell Culture of Glioma Specimens for in Vitro Preclinical Studies
Primary Cell Culture of Surgical Glioma Specimens for Invitro Preclinical Studies
Status: Enrolling
Updated: 6/24/2011
Albany Medical Center
2438
mi
from 91732
Albany, NY
Click here to add this to my saved trials
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Status: Enrolling
Updated:  6/27/2011
Riley Children's Hospital
1793
mi
from 91732
Indianapolis, IN
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Status: Enrolling
Updated: 6/27/2011
Riley Children's Hospital
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Status: Enrolling
Updated:  6/27/2011
Indiana University School of Nursing
1793
mi
from 91732
Indianapolis, IN
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Status: Enrolling
Updated: 6/27/2011
Indiana University School of Nursing
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Status: Enrolling
Updated:  6/27/2011
SSM Cardinal Glennon Children's Hospital
1572
mi
from 91732
St. Louis, MO
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Status: Enrolling
Updated: 6/27/2011
SSM Cardinal Glennon Children's Hospital
1572
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Status: Enrolling
Updated:  6/27/2011
Barnes Jewish Hospital
1569
mi
from 91732
St. Louis, MO
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Timely End-of-Life Communication to Parents of Children With Brain Tumors
Status: Enrolling
Updated: 6/27/2011
Barnes Jewish Hospital
1569
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
Status: Enrolling
Updated:  7/26/2011
Legacy Health System
829
mi
from 91732
Portland, OR
A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
Status: Enrolling
Updated: 7/26/2011
Legacy Health System
829
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Vagus Nerve Stimulation to Augment Recovery From Minimally Conscious or Persistently Vegetative States After Traumatic Brain Injury
Vagus Nerve Stimulation to Augment Recovery From Minimally Conscious or Persistently Vegetative States After Traumatic Brain Injury
Status: Enrolling
Updated:  8/9/2011
Manhattan Va NYHHCS
2433
mi
from 91732
New York, NY
Vagus Nerve Stimulation to Augment Recovery From Minimally Conscious or Persistently Vegetative States After Traumatic Brain Injury
Vagus Nerve Stimulation to Augment Recovery From Minimally Conscious or Persistently Vegetative States After Traumatic Brain Injury
Status: Enrolling
Updated: 8/9/2011
Manhattan Va NYHHCS
2433
mi
from 91732
New York, NY
Click here to add this to my saved trials
Photoacoustic Endoscopy in Endometrial Cancer
A Pilot Study of Photoacoustic Endoscopy in Endometrial Cancer
Status: Enrolling
Updated:  12/22/2011
Washington University School of Medicine
1569
mi
from 91732
Saint Louis, MO
Photoacoustic Endoscopy in Endometrial Cancer
A Pilot Study of Photoacoustic Endoscopy in Endometrial Cancer
Status: Enrolling
Updated: 12/22/2011
Washington University School of Medicine
1569
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
A Phase I/II Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors
Status: Enrolling
Updated:  12/30/2011
Columbia University Department of Neurosurgery
2435
mi
from 91732
New York City, NY
Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
A Phase I/II Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors
Status: Enrolling
Updated: 12/30/2011
Columbia University Department of Neurosurgery
2435
mi
from 91732
New York City, NY
Click here to add this to my saved trials
MRI-Guided Laser Induced Thermal Therapy
MRI-Guided Laser-Induced Thermal Therapy for Cytoreduction of Inoperable Grade III/IV GLiomas Prior to Chemotherapy and Radiation
Status: Enrolling
Updated:  1/20/2012
Robert Wood Johnson University Hospital
2410
mi
from 91732
New Brunswick, NJ
MRI-Guided Laser Induced Thermal Therapy
MRI-Guided Laser-Induced Thermal Therapy for Cytoreduction of Inoperable Grade III/IV GLiomas Prior to Chemotherapy and Radiation
Status: Enrolling
Updated: 1/20/2012
Robert Wood Johnson University Hospital
2410
mi
from 91732
New Brunswick, NJ
Click here to add this to my saved trials
Arterial Spin Labeling Perfusion Magnetic Resonance (MR) Imaging in Pediatric Brain Tumors
CHP-901:Arterial Spin Labeling Perfusion MR Imaging in Pediatric Brain Tumors
Status: Enrolling
Updated:  1/30/2012
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Arterial Spin Labeling Perfusion Magnetic Resonance (MR) Imaging in Pediatric Brain Tumors
CHP-901:Arterial Spin Labeling Perfusion MR Imaging in Pediatric Brain Tumors
Status: Enrolling
Updated: 1/30/2012
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
RAD001 and Erlotinib in Patients With Neuroendocrine Tumors
A Phase II Study to Evaluate the Safety and Efficacy of RAD001 Plus Erlotinib in Patients With Well- to Moderately-Differentiated Neuroendocrine Tumors
Status: Enrolling
Updated:  3/19/2012
UCSF Helen Diller Family Comprehensive Cancer Center
356
mi
from 91732
San Francisco, CA
RAD001 and Erlotinib in Patients With Neuroendocrine Tumors
A Phase II Study to Evaluate the Safety and Efficacy of RAD001 Plus Erlotinib in Patients With Well- to Moderately-Differentiated Neuroendocrine Tumors
Status: Enrolling
Updated: 3/19/2012
UCSF Helen Diller Family Comprehensive Cancer Center
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Molecular Analysis of Retinoblastoma
Molecular Analysis of Retinoblastoma
Status: Enrolling
Updated:  4/11/2012
St. Jude Children's Research Hostpital
1587
mi
from 91732
Memphis, TN
Molecular Analysis of Retinoblastoma
Molecular Analysis of Retinoblastoma
Status: Enrolling
Updated: 4/11/2012
St. Jude Children's Research Hostpital
1587
mi
from 91732
Memphis, TN
Click here to add this to my saved trials
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated:  4/13/2012
Connecticut Children's Hospital
2497
mi
from 91732
Hartford, CT
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated: 4/13/2012
Connecticut Children's Hospital
2497
mi
from 91732
Hartford, CT
Click here to add this to my saved trials
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated:  4/13/2012
Arnold Palmer Hospital for Children- MD Anderson
2185
mi
from 91732
Orlando, FL
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated: 4/13/2012
Arnold Palmer Hospital for Children- MD Anderson
2185
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated:  4/13/2012
National Cancer Institute
2277
mi
from 91732
Bethesda, MD
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated: 4/13/2012
National Cancer Institute
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated:  4/13/2012
Helen DeVos Children's Hospital
1840
mi
from 91732
Grand Rapids, MI
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated: 4/13/2012
Helen DeVos Children's Hospital
1840
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated:  4/13/2012
Children's Mercy Hospital
1341
mi
from 91732
Kansas City, MO
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated: 4/13/2012
Children's Mercy Hospital
1341
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated:  4/13/2012
Cardinal Glennon Children's Medical Center
1569
mi
from 91732
St. Louis, MO
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated: 4/13/2012
Cardinal Glennon Children's Medical Center
1569
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated:  4/13/2012
Levine Children's Hospital
2102
mi
from 91732
Charlotte, NC
Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma
Status: Enrolling
Updated: 4/13/2012
Levine Children's Hospital
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Assessment of Sleep Complaints in Brain Tumor Survivors
Assessment of Sleep Complaints in Brain Tumor Survivors
Status: Enrolling
Updated:  4/24/2012
St. Jude Children's Research Hospital
1587
mi
from 91732
Memphis, TN
Assessment of Sleep Complaints in Brain Tumor Survivors
Assessment of Sleep Complaints in Brain Tumor Survivors
Status: Enrolling
Updated: 4/24/2012
St. Jude Children's Research Hospital
1587
mi
from 91732
Memphis, TN
Click here to add this to my saved trials
Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
A Phase I Study of Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  4/30/2012
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
A Phase I Study of Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 4/30/2012
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials